Search research articles
Contact Us
Filters
Showing results (141-150 of 287) with videos related to
Page
of 29
Sort By:
Journal of Biological Regulators and Homeostatic Agents
|
July 1, 1994
Preliminary study on modulation of the biological effects of tumor necrosis factor-alpha in advanced cancer patients by the pineal hormone melatonin
R Brackowski, B Zubelewicz, W Romanowski, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1992
Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients
P Lissoni, S Barni, A Ardizzoia, et al.
Oncology Reports
|
October 19, 1999
Pre-operative IL-2 immunoprophylaxis of cancer recurrence: long-term clinical results of a phase II study in radically operable colorectal cancer
F Brivio, P Lissoni, L Fumagalli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
August 15, 2001
Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients
P Lissoni, E Fumagalli, F Malugani, et al.
Anticancer Research
|
August 19, 2007
Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach test
G Messina, P Lissoni, E Bartolacelli, et al.
Anticancer Research
|
March 2, 2005
Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer
L Frontini, P Lissoni, M Vaghi, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 11, 2006
Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems
P Lissoni, G Messina, F Brivio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1997
Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2
P Lissoni, M Cazzaniga, S Barni, et al.
The International Journal of Biological Markers
|
July 27, 2001
Stimulation of IL-18 secretion by IL-2 in patients with advanced cancer
P Lissoni, F Rovelli, D Vellani, et al.
Journal of Pineal Research
|
May 8, 1999
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study
P Lissoni, G Tancini, F Paolorossi, et al.
Page
of 29
Search research articles
Search
Showing results (141-150 of 287) with videos related to
Sort By:
Page
of 29
Journal of Biological Regulators and Homeostatic Agents
|
July 1, 1994
Preliminary study on modulation of the biological effects of tumor necrosis factor-alpha in advanced cancer patients by the pineal hormone melatonin
R Brackowski, B Zubelewicz, W Romanowski, et al.
Journal of Biological Regulators and Homeostatic Agents
|
October 1, 1992
Immunological effects of a single evening subcutaneous injection of low-dose interleukin-2 in association with the pineal hormone melatonin in advanced cancer patients
P Lissoni, S Barni, A Ardizzoia, et al.
Oncology Reports
|
October 19, 1999
Pre-operative IL-2 immunoprophylaxis of cancer recurrence: long-term clinical results of a phase II study in radically operable colorectal cancer
F Brivio, P Lissoni, L Fumagalli, et al.
Journal of Biological Regulators and Homeostatic Agents
|
August 15, 2001
Stimulation of IL-12 secretion by GM-CSF in advanced cancer patients
P Lissoni, E Fumagalli, F Malugani, et al.
Anticancer Research
|
August 19, 2007
Efficacy of IL-2 immunotherapy in metastatic renal cell carcinoma in relation to the psychic profile as evaluated using the Rorschach test
G Messina, P Lissoni, E Bartolacelli, et al.
Anticancer Research
|
March 2, 2005
Enhancement of the efficacy of weekly low-dose taxotere by the long acting anti-prolactinemic drug cabergoline in pretreated metastatic breast cancer
L Frontini, P Lissoni, M Vaghi, et al.
Journal of Biological Regulators and Homeostatic Agents
|
April 11, 2006
Cortisol response to an acute injection of IL-2 in healthy subjects and cancer patients: a first immunoneuroendocrine standardized clinical test to explore the interactions between immune and neuroendocrine systems
P Lissoni, G Messina, F Brivio, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 1, 1997
Acute effects of pamidronate administration on serum levels of interleukin-6 in advanced solid tumour patients with bone metastases and their possible implications in the immunotherapy of cancer with interleukin-2
P Lissoni, M Cazzaniga, S Barni, et al.
The International Journal of Biological Markers
|
July 27, 2001
Stimulation of IL-18 secretion by IL-2 in patients with advanced cancer
P Lissoni, F Rovelli, D Vellani, et al.
Journal of Pineal Research
|
May 8, 1999
Chemoneuroendocrine therapy of metastatic breast cancer with persistent thrombocytopenia with weekly low-dose epirubicin plus melatonin: a phase II study
P Lissoni, G Tancini, F Paolorossi, et al.
Page
of 29